Ascendis Pharma Valuation
| ASND Stock | USD 222.03 0.12 0.05% |
At this time, the firm appears to be fairly valued. Ascendis Pharma AS shows a prevailing Real Value of $230.81 per share. The current price of the firm is $222.03. Our model approximates the value of Ascendis Pharma AS from analyzing the firm fundamentals such as profit margin of (0.36) %, and Return On Equity of -8.18 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Ascendis Pharma's price fluctuation is very steady at this time. Calculation of the real value of Ascendis Pharma AS is based on 3 months time horizon. Increasing Ascendis Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ascendis stock is determined by what a typical buyer is willing to pay for full or partial control of Ascendis Pharma AS. Since Ascendis Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ascendis Stock. However, Ascendis Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 222.03 | Real 230.81 | Hype 224.87 |
The real value of Ascendis Stock, also known as its intrinsic value, is the underlying worth of Ascendis Pharma AS Company, which is reflected in its stock price. It is based on Ascendis Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ascendis Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ascendis Pharma AS helps investors to forecast how Ascendis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ascendis Pharma more accurately as focusing exclusively on Ascendis Pharma's fundamentals will not take into account other important factors: About Ascendis Pharma Valuation
The stock valuation mechanism determines Ascendis Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ascendis Pharma. We calculate exposure to Ascendis Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ascendis Pharma's related companies.Ascendis Pharma AS, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Ascendis Pharma is traded on NASDAQ Exchange in the United States.
Ascendis Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ascendis Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 57.9 M | |
| Forward Price Earnings | 42.5532 |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |